Solventum Corporation (NYSE:SOLV) Q2 2025 Earnings Call Transcript
Operator: Good afternoon. My name is Kate, and I will be your conference call operator today. I would like to welcome everyone to Solventum's Second Quarter 2025 Earnings Call.
Solventum Corp (SOLV)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Motley Fool Asset Management Bryan Hinmon | 4,662 | $353,566 | +9% | 0.02% |
| 2. | Platinum Asset Management Kerr Neilson | 217 | $16,457 | 0% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,492,661 | $416,563,410 | 2.23% | |
| 2. | 3,670,757 | $278,362,632 | 0.31% | |
| 3. | 3,563,792 | $269,116,410 | 0.02% | |
| 4. | 883,392 | $66,996,446 | 5.22% | |
| 5. | 857,478 | $65,031,123 | 0.01% |
News See All
Morgan Stanley Upgrades Solventum (SOLV) on Growth Potential
Solventum Corporation (NYSE:SOLV) ranks among the best medical stocks to buy according to analysts.
11 Best Medical Stocks to Buy According to Analysts
As macroeconomic headwinds, regulatory reforms, and geopolitical concerns converge in the second half of 2025, PwC predicts that the health industry's resilience and adaptability will be put to the test...
Solventum Corp (SOLV) Upgraded to a ‘Buy’ at Argus Research
Solventum Corporation (NYSE:SOLV) is one of the 15 successful spin-off companies.
15 Successful Spin-Off Companies and Their 2025 Returns
Don’t chase the markets; instead, wait for things to cool off. That’s the sentiment echoed across Wall Street, with markets at record highs.
Solventum Amends Thermo Fisher Deal, Retains Water Filtration Business
Solventum Corporation (NYSE:SOLV) is one of the best new stocks to buy now. On June 25, Solventum announced an amendment to its transaction agreement with Thermo Fisher Scientific Inc. (NYSE:TMO).
13 Best New Stocks to Buy Now
On June 21, Ashley MacNeill, Vista Equity Partners' head of equity capital markets, joined CNBC's 'Closing Bell' to discuss outlooks on the IPO market.
Solventum Corporation (NYSE:SOLV) Q1 2025 Earnings Call Transcript
Operator: Good afternoon. My name is Amy [ph] and I will be your conference call operator for today. I would like to welcome everyone to the Solventum First Quarter 2025 Earnings Call.
Billionaire Seth Klarman’s 10 Stock Picks with Huge Upside Potential
Seth Klarman is a legendary name in the hedge fund space. He entered Wall Street straight out of college, where he worked as an analyst for Mutual Shares Corporation.
10 Best New Stocks to Buy According to Billionaires
International IPO activity during the first quarter of 2025 was characterized by profound uncertainty coming from geo-political shifts and the ever-changing tariff policies around the globe.
Billionaire Hedge Funds
